Somatostatin-28 (1-14) 2 mg | ≥95%
LKT Laboratories, Inc.
Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.
More Information Supplier PageSearch Results
Somatostatin-28 (1-14) 1 mg | ≥95%
LKT Laboratories, Inc.
Endogenous neuropeptide hormone; somatostatin agonist, GABA modulator, P/Q-type, N-type, and L-type voltage-gated Ca2+ channel modulator.
More Information Supplier PageSperact 5 mg | ≥95%
LKT Laboratories, Inc.
Peptide, derived from egg outer envelope; K+ channel activator, speract SRCR agonist.
More Information Supplier PageSperact 2 mg | ≥95%
LKT Laboratories, Inc.
Peptide, derived from egg outer envelope; K+ channel activator, speract SRCR agonist.
More Information Supplier PageSperact 1 mg | ≥95%
LKT Laboratories, Inc.
Peptide, derived from egg outer envelope; K+ channel activator, speract SRCR agonist.
More Information Supplier PageSubstance P (1-4) 1 mg | ≥95%
LKT Laboratories, Inc.
Endogenous tachykinin peptide, involved in inflammation, stress signaling, nociception; NK1 agonist.
More Information Supplier PageSubstance P (1-7) 5 mg | ≥95%
LKT Laboratories, Inc.
Endogenous tachykinin peptide, involved in inflammation, stress signaling, nociception; NK1 agonist.
More Information Supplier PageSubstance P (1-7) 2 mg | ≥95%
LKT Laboratories, Inc.
Endogenous tachykinin peptide, involved in inflammation, stress signaling, nociception; NK1 agonist.
More Information Supplier PageSubstance P (1-7) 1 mg | ≥95%
LKT Laboratories, Inc.
Endogenous tachykinin peptide, involved in inflammation, stress signaling, nociception; NK1 agonist.
More Information Supplier PageSubstance P (1-9) 5 mg | ≥95%
LKT Laboratories, Inc.
Endogenous tachykinin peptide, involved in inflammation, stress signaling, nociception; NK1 agonist.
More Information Supplier Page